Leading pediatric expert takes on director role for hematology and oncology.
- Dr. Roth has extensive experience in pediatric hematology/oncology.
- Hassenfeld Children's Hospital emphasizes specialized care.
- New role aims to enhance patient outcomes.
Lisa G. Roth, MD, has been appointed the director of pediatric hematology/oncology at Hassenfeld Children's Hospital at NYU Langone. With a wealth of experience in this field, Dr. Roth is set to lead the department in providing specialized medical care. Her expertise promises to advance the hospital's mission of delivering comprehensive treatment to children with blood disorders and cancers.
Dr. Roth previously held leadership roles in pediatric hematology/oncology, contributing to advancements in clinical care and research. She aims to enhance patient outcomes through innovative treatment approaches and collaboration within the multidisciplinary team at Hassenfeld Children's Hospital. The hospital is known for its commitment to providing high-quality care and support to its young patients and their families.
Her leadership is expected to strengthen the program's clinical services and research initiatives. Dr. Roth's appointment comes at a time when there is a growing focus on improving pediatric hematological and oncological care, aligning with the hospital's goals of expanding its outreach and enhancing care protocols for better health results.
